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Background: Blastocystis sp. is one of the most prevalent parasites found in human stool and has been recently
considered an opportunistic emerging pathogen in immunocompromised individuals. However, cases of invasive
intestinal infections and skin rashes have been attributed to infection by Blastocystis sp in immunocompetent
individuals, suggesting that it is an emerging parasite with pathogenic potential.
Findings: We present a case of a 22 year old female patient who complained of pain in the left hypochondrium.
Ultrasonography and abdominal computed tomography scans showed two splenic cysts. The cyst fluid analysis
demonstrated numerous Blastocystis sp.; PCR and DNA sequencing analyses confirmed the presence of Blastocystis subtype 3.
Conclusions: This is, to our knowledge, the first case report of the presence of Blastocystis subtype 3 in extra-intestinal
organs and is strong evidence that Blastocystis sp. is potentially pathogenic and invasive. However, further studies are
required to determine the pathogenicity of the parasite.
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Blastocystis spp. are parasites of the intestinal tract found
in many hosts including humans [1]. This pathogen is
commonly found in apparently healthy and asymptomatic
individuals and in patients with gastrointestinal disease. Its
pathogenicity has been reported in the literature in im-
munocompromised pediatric, cancer, and HIV-infected pa-
tients [2-5], however, the clinical relevance of Blastocystis
sp. in immunocompetent individuals remains unclear. The
association between Blastocystis sp. and arthritis, dermato-
logical disorders, and irritable bowel syndrome [6-8] have
also been reported. In addition, its invasive potential has
been suggested in animal models [9,10] and in humans
[11-13]. Recently, cases of enteroinvasion by Blastocystis sp
were shown in vivo through endoscopy and biopsy analyses
[13]. In this case report, Blastocystis sp. was detected in ul-
cers in the cecum, transverse colon, and rectum of an im-
munocompetent patient.
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unless otherwise stated.However, recent phylogenetic analyses suggest limiting its
name to “Blastocystis species” because of their genetic di-
versity. This parasite has been considered as a species
complex comprising 13 subtypes, of which at least nine
have been found in humans [14]. Furthermore, they ex-
hibit wide genetic diversity that is sufficient to assign them
to different species [15]. The confirmation of their species
status and determination of virulence and pathogenic pro-
files might explain why some patients are asymptomatic
while others present clinical symptoms [16].
Blastocystis spp. was discovered over a century ago,
however, many issues regarding its infection still remain
unanswered. Accumulating evidence reinforces the patho-
genic potential of Blastocystis sp. in immunocompetent in-
dividuals [6-8]; however, systematic studies characterizing
different clinical isolates of Blastocystis subtypes and new
diagnostic approaches are needed to improve our under-
standing about these cases. This is the first case report de-
scribing the presence of Blastocystis sp. in the fluid of
splenic cysts. According to our observation, the following
question is raised: ‘Can Blastocystis be the culprit for the
formation of splenic cysts or is this association based on
other reasons?’Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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A 22 year-old white female, residing in Niteroi, Rio de
Janeiro State, Brazil, sought treatment in 2009 reporting
localized pain in the left hypochondrium. The ultrasonog-
raphy showed a 15.1 × 11.1 cm cyst in the spleen. In 2012,
this patient returned for medical attention due to an in-
tensification of the pain that affected her walking. An ab-
dominal computed tomography (CT) scan revealed the
presence of two spleen cysts (11 × 11 cm) with peripheral
calcifications (one intra- and one extra-splenic). The
hematological and biochemical tests showed results within
normal limits and the chest x-ray was normal, however,
the urine culture was positive for Streptococcus agalactiae.
Surgical treatment was recommended and, one month
prior to operation, the patient received the pneumococcal
Haemophilus influenzae and meningococcal vaccines. A
laparoscopic excision of the splenic cyst was performed
and the postoperative recovery was uneventful; the patient
was discharged on the second post-operative day. The
cytological examination of cyst fluid showed the presence
of histiocytes, lymphocytes, polymorphonuclear leuko-
cytes, and lysed erythrocytes. No evidence of cancerous
cells was observed and the biochemistry results were as
follows: 3.6 g/dl albumin, 3 mg/dl glucose, 137mEq/L so-
dium chloride, 3.9 Eq/L potassium chloride, 1132 U/L lac-
tate dehydrogenase (LDH), 76 U/L amylase, and 65 U/L
lypase. Furthermore, the presence of crystals and Blasto-
cystis sp. were observed in the microscopic examinations
of the fluid contained in the cyst (Figure 1). The presence
of Blastocystis sp. was further confirmed by PCR using
primers and conditions previously described [17] and sub-
sequent sequencing. The obtained small subunit ribosomalFigure 1 Light microscope images of Blastocystis sp. in splenic fluid s
wet slides), 40× magnification. E and F (unstained wet slides), G and H (iodDNA nucleotide partial sequence was compared to
other sequences available in this database using the
BLASTN program from the National Center for Biotech-
nology Information (NCBI) server (http://www.ncbi.nlm.
nih.gov/BLAST). This analysis showed 99% similarity be-
tween our sequence and the Blastocystis sp. OSU2 se-
quence (GenBank: EU679346) characterized as Blastocystis
subtype 3. The phylogenetic analysis showed that sequence
of this study clustered with Blastocystis sp OSU2 sequence
(Figure 2).
Discussion
Splenic cysts constitute very rare clinical entities. They
may occur secondary to trauma or parasitic infestations,
particularly by Echinococcus granulosus [18,19]. Cases of
isolated splenic involvement in hydatid disease are not
very frequent even in endemic regions [18]. Interestingly,
this report describes the presence of Blastocystis subtype 3
in splenic cysts, a parasite mostly found in human stool. A
previous case study described Blastocystis present in the
liver abscess aspirate of a patient with history of fever,
watery diarrhea and high Anti-Entamoeba histolytica anti-
body titer [11]. Although the pathogenic mechanisms are
unclear; we speculate that two hypotheses could be con-
sidered to explain how the Blastocystis sp got into the
spleen. First, Blastocystis sp might penetrate and invade
the intestinal mucosa and submucosa causing ulcers, and
progress through the blood and/or lymphatic system and
migrate to the spleen. Second, the parasite might gain ac-
cess to extra-intestinal sites with the help of coinfections
or other pathological circumstances. To complement these
hypotheses, Blastocystis sp have to survive during infection,pecimens. A and B (unstained wet slides), C and D (iodine stained
ine stained wet slides), 100× magnification.
Figure 2 Phylogenetic analysis of partial SSU rRNA sequences of Blastocystis isolates. Neighbor-Joining tree displaying the relationships of
Blastocystis isolates, inferred by analysis of partial SSU rDNA sequence data using Kimura’s 2 parameter distance estimates. The number at each
branch point represents the percentage of bootstrap support calculated from 1,000 trees. The sequences used for comparison were from
Genbank. The triangle indicates isolates from this study.
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environment in intestine, blood and escaping host defense
mechanisms. There are few studies addressing the mech-
anism of pathogenesis, regarding cellular microbiology,
immune evasion, and life cycle of Blastocystis sp. This
parasite one of the most difficult organisms to identify in
stool samples because of their morphological biodiversity;
some of the commonly reported forms in culture or in
fecal specimens are vacuolar, granular or amoeboid. How-
ever, other forms that might occur with relative frequency
might be missed by untrained examiners [1]. Conversely,
the lack of standardized diagnosis may also lead to misin-
terpretation of results [1]. Recently, a study revealed poor
agreement in reporting Blastocystis sp. positive specimens
when comparing the diagnostic performance of various
European reference laboratories [20]. Several molecular
epidemiological studies suggest a possible correlation be-
tween subtypes and clinical presentations of Blastocystis in-
fections. Other studies observed no association between
presence of this organism and disease [21,22]. These dis-
crepant results might be explained by subtypes with differ-
ences in virulence, or by low sensitivity in the diagnosis
techniques used. This scenario is strikingly similar to that of
an erroneous diagnosis of Entamoeba histolytica. For many
years, the virulence and pathogenicity of E. histolytica was
questioned until molecular techniques irrefutably showed
that there are two genetically distinct, but morphologically
identical, species in what was formerly known as E. histoly-
tica. Differences in the pathogenesis of E. histolytica and E.dispar also helped explain the epidemiology, presentation of
symptoms, and pathology of amoebiasis [23].
Currently, there is not enough evidence showing that
Blastocystis sp. is a nonpathogenic organism and its as-
sociation with gastrointestinal diseases raises questions
about its pathogenicity [5-8]. Moreover, there are accu-
mulating data suggesting its pathogenic potential in im-
munocompetent individuals [1,12-14].
The genome of Blastocystis subtype 7 encodes prote-
ases, hexose digestion enzymes, lectins, protease inhibi-
tors, and glycosyltransferases besides several proteins
that are predicted to be secreted [24]. The roles of some of
these proteins are known in other parasites [25] with dir-
ect connections to their pathogenicity in processes such as
host cell invasion, excystation, metabolism, cytoadher-
ence, and other virulence functions [24]. Thus, proteo-
mics and transcriptomic analyses will be useful in order
to show whether these predicted proteins have any role
in the pathogenesis of Blastocystis.
Protease activity has been described in Blastocystis spp.
isolated from symptomatic patients [26-28]. In addition,
other studies have demonstrated that cysteine proteases
from Blastocystis can increase epithelial permeability by
modulating the tight junction complex [29], induce pro-
inflammatory cytokine interleukin-8 (IL-8) [30], and de-
grade human immunoglobulin A (IgA) [31]. Cysteine
proteases are important enzymes for host invasion and
infection and are well recognized as virulence factors in
pathogenic protozoa [25].
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splenic cysts. The literature on the molecular analysis of
human Blastocystis isolates suggests that they are mostly of
genotype subtype 3. Genotype variability has been reported
to play an influential role in the pathogenicity of Blastocys-
tis [32,33]. However, previous studies have associated sub-
types 1, 4, and 7 with human pathology, whereas subtypes
2 and 3 predominate among healthy carriers [12]. Infec-
tions with mixed subtypes, and the high degree of genetic
diversity among subtypes, obscure possible correlations be-
tween pathogenicity and Blastocystis subtypes [5,34,35].
Conclusions
To our knowledge, this is the first report describing
Blastocystis subtype 3 in an extra-intestinal organ. We
have no knowledge as to how the parasite gained access
to the spleen. The answer to this question will deepen
our understanding about the pathogenicity of Blastocys-
tis sp. Its pathogenic potential is a relevant threat to im-
munocompetent individuals and this report emphasizes
the importance of an increased awareness and recogni-
tion of this pathogen.
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